Towards understanding the kallikrein-kinin system: insights from measurement of kinin peptides - PubMed (original) (raw)

Review

Towards understanding the kallikrein-kinin system: insights from measurement of kinin peptides

D J Campbell. Braz J Med Biol Res. 2000 Jun.

Free article

Abstract

The kallikrein-kinin system is complex, with several bioactive peptides that are formed in many different compartments. Kinin peptides are implicated in many physiological and pathological processes including the regulation of blood pressure and sodium homeostasis, inflammatory processes, and the cardioprotective effects of preconditioning. We established a methodology for the measurement of individual kinin peptides in order to study the function of the kallikrein-kinin system. The levels of kinin peptides in tissues were higher than in blood, confirming the primary tissue localization of the kallikrein-kinin system. Moreover, the separate measurement of bradykinin and kallidin peptides in man demonstrated the differential regulation of the plasma and tissue kallikrein-kinin systems, respectively. Kinin peptide levels were increased in the heart of rats with myocardial infarction, in tissues of diabetic and spontaneously hypertensive rats, and in urine of patients with interstitial cystitis, suggesting a role for kinin peptides in the pathogenesis of these conditions. By contrast, blood levels of kallidin, but not bradykinin, peptides were suppressed in patients with severe cardiac failure, suggesting that the activity of the tissue kallikrein-kinin system may be suppressed in this condition. Both angiotensin converting enzyme (ACE) and neutral endopeptidase (NEP) inhibitors increased bradykinin peptide levels. ACE and NEP inhibitors had different effects on kinin peptide levels in blood, urine, and tissues, which may be accounted for by the differential contributions of ACE and NEP to kinin peptide metabolism in the multiple compartments in which kinin peptide generation occurs. Measurement of the levels of individual kinin peptides has given important information about the operation of the kallikrein-kinin system and its role in physiology and disease states.

PubMed Disclaimer

Cited by

Mass spectrometric study of variation in kinin peptide profiles in nasal fluids and plasma of adult healthy individuals.
Gangnus T, Bartel A, Burckhardt BB. Gangnus T, et al. J Transl Med. 2022 Mar 29;20(1):146. doi: 10.1186/s12967-022-03332-8. J Transl Med. 2022. PMID: 35351153 Free PMC article.
The kinin system--bradykinin: biological effects and clinical implications. Multiple role of the kinin system--bradykinin.
Golias Ch, Charalabopoulos A, Stagikas D, Charalabopoulos K, Batistatou A. Golias Ch, et al. Hippokratia. 2007 Jul;11(3):124-8. Hippokratia. 2007. PMID: 19582206 Free PMC article.
Bradykinin acutely inhibits activity of the epithelial Na+ channel in mammalian aldosterone-sensitive distal nephron.
Zaika O, Mamenko M, O'Neil RG, Pochynyuk O. Zaika O, et al. Am J Physiol Renal Physiol. 2011 May;300(5):F1105-15. doi: 10.1152/ajprenal.00606.2010. Epub 2011 Feb 16. Am J Physiol Renal Physiol. 2011. PMID: 21325499 Free PMC article.
Role of Mas Receptor Antagonist A799 in Renal Blood Flow Response to Ang 1-7 after Bradykinin Administration in Ovariectomized Estradiol-Treated Rats.
Dehghani A, Saberi S, Nematbakhsh M. Dehghani A, et al. Adv Pharmacol Sci. 2015;2015:801053. doi: 10.1155/2015/801053. Epub 2015 Sep 3. Adv Pharmacol Sci. 2015. PMID: 26421009 Free PMC article.
Bradykinin activation of extracellular signal-regulated kinases in human trabecular meshwork cells.
Webb JG, Yang X, Crosson CE. Webb JG, et al. Exp Eye Res. 2011 Jun;92(6):495-501. doi: 10.1016/j.exer.2011.03.009. Epub 2011 Mar 21. Exp Eye Res. 2011. PMID: 21426904 Free PMC article.

Towards understanding the kallikrein-kinin system: insights from measurement of kinin peptides - PubMed (original) (raw)